# The association between remnant cholesterol and the risk of osteoporotic vertebral fracture in older adults

**Authors:** Changzhi Liu, He Tong, Xifa Gao, Jiangchuan Wang, Zicheng Wei, Yu Wang, Jianhua Wang, Xiao Chen

PMC · DOI: 10.1371/journal.pone.0327171 · PLOS One · 2025-07-29

## TL;DR

This study finds that higher remnant cholesterol levels are linked to a lower risk of vertebral fractures in older adults, especially women.

## Contribution

The study reveals a novel inverse association between remnant cholesterol and vertebral fracture risk in older adults.

## Key findings

- Participants with high remnant cholesterol had a 41% lower fracture risk compared to those with low levels.
- The RC-to-cholesterol ratio was also inversely associated with fracture risk.
- The protective effect of remnant cholesterol was more pronounced in women.

## Abstract

Serum lipid levels have been shown to influence bone mineral density. Additionally, a limited number of studies have suggested that remnant cholesterol (RC) may be linked to the risk of osteoporosis. However, the relationship between RC and fracture risk remains unclear. This study aimed to explore the association between RC levels and the risk of vertebral fractures in a longitudinal cohort.

A total of 1995 participants aged 50 years or older who underwent chest computed tomography (CT) scans for lung cancer screening between July 2016 and December 2019 were included in this study. Follow-up continued until June 2023. The concentration of RC was calculated via the following formula: total cholesterol minus the sum of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol. The RC-to-cholesterol ratio was also determined. The participants were divided into low and high groups for RC, and the RC-to-cholesterol ratio was based on the median values. Vertebral fractures were assessed via the Genant semiquantitative classification system on CT-reconstructed sagittal images.

During a median follow-up period of 60 months, 95 new vertebral fractures were recorded. The incidence of fractures was significantly greater among participants with low RC levels than among those with high RC levels (6.4% vs. 3.1%, P < 0.01). A multivariate Cox proportional hazards model indicated that individuals with high RC levels had a 41% lower risk of vertebral fractures than those with low RC levels did (adjusted hazard ratio [aHR]: 0.48, 95% confidence interval [CI]: 0.24--0.93). Similar findings were observed for the RC-to-cholesterol ratio (aHR: 0.40, 95% CI: 0.21–0.79). Restricted cubic spline analysis further demonstrated that the risk of vertebral fractures decreased as the RC level and the RC-to-cholesterol ratio increased. Subgroup analysis revealed that the association between RC and fracture risk was mainly observed in women.

Higher levels of remnant cholesterol and a higher RC-to-cholesterol ratio were associated with a reduced risk of vertebral fractures, particularly in women.

## Linked entities

- **Diseases:** osteoporosis (MONDO:0005298)

## Full-text entities

- **Genes:** ATHS (atherosclerosis susceptibility (lipoprotein associated)) [NCBI Gene 470] {aka ALP}, COG2 (component of oligomeric golgi complex 2) [NCBI Gene 22796] {aka CDG2Q, LDLC}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, TNFSF11 (TNF superfamily member 11) [NCBI Gene 8600] {aka CD254, ODF, OPGL, OPTB2, RANKL, TNLG6B}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}
- **Diseases:** fragility fractures (MESH:D005600), inflammatory (MESH:D007249), Low muscle quality (MESH:D009800), skeletal disorder (MESH:C564967), tumors (MESH:D009369), vertebral metastases (MESH:D009362), RC (MESH:C535937), Vertebral fractures (MESH:C535781), cardiovascular diseases (MESH:D002318), metabolic bone diseases (MESH:D001851), mass (MESH:C536030), Fracture (MESH:D050723), wrist fracture (MESH:D000092503), Bone mass (MESH:D001847), lung cancer (MESH:D008175), diabetes (MESH:D003920), Osteoporosis (MESH:D010024), Dyslipidemia (MESH:D050171), obese (MESH:D009765), hip fracture (MESH:D006620), bone attenuation (MESH:C538265), abdominal obesity (MESH:D056128), Osteoporotic fractures (MESH:D058866)
- **Chemicals:** Testosterone (MESH:D013739), TG (MESH:D014280), Lipid (MESH:D008055), Oxidized lipids (-), glucose (MESH:D005947), Cholesterol (MESH:D002784)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12306751/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12306751/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12306751/full.md

---
Source: https://tomesphere.com/paper/PMC12306751